Cellular and T cell engager Immunotherapy
Exploring MAGE-A1 as a therapeutic target in advanced Multiple Myeloma: Expression analysis and phase 1 clinical trial of MAGE-A1-directed TCR-1367 T cells
Josefine Krüger, MD
Physician
Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Germany